Nextech Invest
Latest statistics and disclosures from Nextech Invest's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVMD, ORIC, TYRA, CRGX, ARVN, and represent 72.81% of Nextech Invest's stock portfolio.
- Added to shares of these 5 stocks: TYRA (+$25M), RLAY (+$21M), SLN (+$21M), Boundless Bio (+$18M), ORIC (+$14M).
- Started 2 new stock positions in SLN, Boundless Bio.
- Reduced shares in these 3 stocks: Ambrx Biopharma (-$45M), ARVN (-$12M), MRSN (-$9.5M).
- Sold out of its position in Ambrx Biopharma.
- Nextech Invest was a net buyer of stock by $32M.
- Nextech Invest has $631M in assets under management (AUM), dropping by 17.51%.
- Central Index Key (CIK): 0001911010
Tip: Access up to 7 years of quarterly data
Positions held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Nextech Invest
Nextech Invest holds 12 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Revolution Medicines (RVMD) | 32.2 | $203M | 6.3M | 32.23 |
|
|
Oric Pharmaceuticals (ORIC) | 11.5 | $73M | +23% | 5.3M | 13.75 |
|
Tyra Biosciences (TYRA) | 10.5 | $67M | +61% | 4.1M | 16.40 |
|
Cargo Therapeutics (CRGX) | 9.4 | $59M | 2.6M | 22.32 |
|
|
Arvinas Ord (ARVN) | 9.2 | $58M | -16% | 1.4M | 41.28 |
|
Tango Therapeutics (TNGX) | 7.0 | $44M | 5.5M | 7.94 |
|
|
Relay Therapeutics (RLAY) | 5.1 | $32M | +185% | 3.8M | 8.30 |
|
Cullinan Oncology (CGEM) | 3.3 | $21M | 1.2M | 17.04 |
|
|
Silence Therapeutics Ads (SLN) | 3.3 | $21M | NEW | 952k | 21.60 |
|
Silverback Therapeutics (SPRY) | 3.1 | $20M | 1.9M | 10.22 |
|
|
Boundless Bio | 2.8 | $18M | NEW | 1.2M | 14.25 |
|
Mersana Therapeutics (MRSN) | 2.7 | $17M | -35% | 3.9M | 4.48 |
|
Past Filings by Nextech Invest
SEC 13F filings are viewable for Nextech Invest going back to 2021
- Nextech Invest 2024 Q1 filed May 15, 2024
- Nextech Invest 2023 Q4 filed Feb. 14, 2024
- Nextech Invest 2023 Q3 filed Nov. 14, 2023
- Nextech Invest 2023 Q2 filed Aug. 14, 2023
- Nextech Invest 2023 Q1 filed May 12, 2023
- Nextech Invest 2022 Q4 filed Feb. 14, 2023
- Nextech Invest 2022 Q3 filed Nov. 14, 2022
- Nextech Invest 2022 Q2 filed Aug. 1, 2022
- Nextech Invest 2021 Q4 restated filed May 16, 2022
- Nextech Invest 2022 Q1 filed May 16, 2022
- Nextech Invest 2021 Q4 filed Feb. 14, 2022